IRIS
GATTEI, VALTER
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.004
EU - Europa 855
AS - Asia 542
SA - Sud America 78
Continente sconosciuto - Info sul continente non disponibili 37
AF - Africa 19
OC - Oceania 2
Totale 2.537
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 947
RU - Federazione Russa 248
IT - Italia 187
SG - Singapore 178
IE - Irlanda 111
CN - Cina 88
DE - Germania 73
BR - Brasile 65
SE - Svezia 64
HK - Hong Kong 62
VN - Vietnam 62
BD - Bangladesh 58
FR - Francia 44
IN - India 41
GB - Regno Unito 36
CA - Canada 27
UA - Ucraina 22
PL - Polonia 18
MX - Messico 11
FI - Finlandia 10
KR - Corea 8
JP - Giappone 7
LT - Lituania 7
AT - Austria 6
BJ - Benin 6
ID - Indonesia 6
TR - Turchia 6
AR - Argentina 5
ZA - Sudafrica 5
CZ - Repubblica Ceca 4
ES - Italia 4
IQ - Iraq 4
NL - Olanda 4
UZ - Uzbekistan 4
BE - Belgio 3
CO - Colombia 3
CR - Costa Rica 3
EE - Estonia 3
EG - Egitto 3
GR - Grecia 3
HR - Croazia 3
JM - Giamaica 3
KE - Kenya 3
PK - Pakistan 3
CH - Svizzera 2
EC - Ecuador 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
MY - Malesia 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
CL - Cile 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GP - Guadalupe 1
IL - Israele 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
NI - Nicaragua 1
PH - Filippine 1
PS - Palestinian Territory 1
TN - Tunisia 1
TO - Tonga 1
TW - Taiwan 1
ZM - Zambia 1
Totale 2.500
Salva come PNG Salva come JPEG
Città #
San Jose 140
Dublin 110
Ashburn 73
Council Bluffs 65
Singapore 63
Hong Kong 61
Jacksonville 43
Beijing 38
Los Angeles 31
Columbus 30
Novara 25
Moscow 24
Lauterbourg 23
Ho Chi Minh City 22
New York 20
St Louis 18
Phoenix 17
Warsaw 17
Milan 16
Santa Clara 16
Boardman 15
Piemonte 15
Vercelli 15
Lawrence 14
Princeton 14
San Bernardino 14
São Paulo 14
Atlanta 13
Chandler 12
Dearborn 12
Munich 11
Buffalo 9
Hanoi 9
Montreal 9
Tornaco 9
Turin 9
Bremen 8
Denver 8
Falkenstein 8
Helsinki 8
Mexico City 8
Orem 8
Seoul 8
Boston 7
Frankfurt am Main 7
Podenzano 7
Redondo Beach 7
Toronto 7
Chennai 6
Chicago 6
Cotonou 6
Dallas 6
London 6
Manchester 6
Rome 6
Tokyo 6
Belo Horizonte 5
Brooklyn 5
Hillsboro 5
Roseto degli Abruzzi 5
Seattle 5
Wilmington 5
Ann Arbor 4
Da Nang 4
Hangzhou 4
Nuremberg 4
Somaglia 4
Stockholm 4
Ankara 3
Athens 3
Brasília 3
Brno 3
City of London 3
Florence 3
Grafing 3
Gunzenhausen 3
Houston 3
Istanbul 3
Jackson 3
Jakarta 3
Johannesburg 3
Kingston 3
North Bergen 3
Olathe 3
Padua 3
Palermo 3
Pittsburgh 3
Poplar 3
Rio de Janeiro 3
San Mateo 3
Santa Rosa Beach 3
Schaumburg 3
Sorocaba 3
Tashkent 3
Vilnius 3
Amsterdam 2
Cagliari 2
Cologno Monzese 2
Delhi 2
Fort Worth 2
Totale 1.330
Salva come PNG Salva come JPEG
Nome #
Molecular clustering on ctDNA improves the prognostic stratification of DLBCL patients compared to ctDNA levels 192
Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement 168
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial 141
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study 113
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia 112
NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways 111
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia 110
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression 110
Mutations in the 3′ untranslated region of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia 108
XPO1 mutations identify early‐stage CLL characterized by shorter time to first treatment and enhanced BCR signalling 107
Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial 104
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases 99
Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma 98
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study 97
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases 95
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab 93
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials 93
Elastin MIcrofibriL INterfacer1 (EMILIN-1) is an alternative prosurvival VLA-4 ligand in chronic lymphocytic leukemia 82
Quality assessment for PCR-based minimal residual disease in Lymphoma: 10 Years of cross-laboratory standardization process within the fondazione italiana linfomi MRD network 81
A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA 80
CD49d expression is included in a revised 4‐factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real‐world experience 73
Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation 67
The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands 63
Efficacy of front‐line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real‐World” study 56
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study 30
CD49d governs immune synapse formation through actin rearrangements and synchronizes BCR signaling in CLL 29
No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d positive CLL mainly expressed in trisomy 12 25
Totale 2.537
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.625
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.625
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202254 0 0 0 4 5 0 3 0 4 2 14 22
2022/2023212 15 13 17 0 10 15 7 15 109 1 3 7
2023/2024106 8 13 9 6 13 1 16 0 0 0 10 30
2024/2025328 7 0 9 2 11 14 41 79 66 21 14 64
2025/20261.279 51 40 53 128 173 104 154 194 95 120 127 40
2026/2027385 56 122 116 91 0 0 0 0 0 0 0 0
Totale 2.537